4.6 Article

MALT1 Auto-Proteolysis Is Essential for NF-κB-Dependent Gene Transcription in Activated Lymphocytes

期刊

PLOS ONE
卷 9, 期 8, 页码 -

出版社

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0103774

关键词

-

资金

  1. FWO [G.0534.12]
  2. 'Belgian Foundation against Cancer' [190-2008]
  3. 'Concerted Research Actions' (GOA) [GOA/11/010]
  4. Swiss National Science Foundation
  5. Oncosuisse
  6. Helmut Horten Foundation

向作者/读者索取更多资源

Mucosa-associated lymphoid tissue 1 (MALT1) controls antigen receptor-mediated signalling to nuclear factor kappa B (NF-kappa B) through both its adaptor and protease function. Upon antigen stimulation, MALT1 forms a complex with BCL10 and CARMA1, which is essential for initial I kappa B alpha phosphorylation and NF-kappa B nuclear translocation. Parallel induction of MALT1 protease activity serves to inactivate negative regulators of NF-kappa B signalling, such as A20 and RELB. Here we demonstrate a key role for auto-proteolytic MALT1 cleavage in B- and T-cell receptor signalling. MALT1 cleavage occurred after Arginine 149, between the N-terminal death domain and the first immunoglobulin-like region, and did not affect its proteolytic activity. Jurkat T cells expressing an un-cleavable MALT1-R149A mutant showed unaltered initial I kappa B alpha phosphorylation and normal nuclear accumulation of NF-kappa B subunits. Nevertheless, MALT1 cleavage was required for optimal activation of NF-kappa B reporter genes and expression of the NF-kappa B targets IL-2 and CSF2. Transcriptome analysis confirmed that MALT1 cleavage after R14(was required to induce NF-kappa B transcriptional activity in Jurkat T cells. Collectively, these data demonstrate that auto-proteolytic MALT1 cleavage controls antigen receptor-induced expression of NF-kappa B target genes downstream of nuclear NF-kappa B accumulation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

Structural Insights into the Binding of Natural Pyrimidine-Based Inhibitors of Class II Aminoacyl-tRNA Synthetases

Luping Pang, Manesh Nautiyal, Steff De Graef, Bharat Gadakh, Valentina Zorzini, Anastassios Economou, Sergei Strelkov, Arthur Van Aerschot, Stephen D. Weeks

ACS CHEMICAL BIOLOGY (2020)

Article Medicine, Research & Experimental

GRK2 suppresses lymphomagenesis by inhibiting the MALT1 proto-oncoprotein

Jing Cheng, Linda R. Klei, Nathaniel E. Hubel, Ming Zhang, Rebekka Schairer, Lisa M. Maurer, Hanna B. Klei, Heejae Kang, Vincent J. Concel, Phillip C. Delekta, Eric Dang, Michelle A. Mintz, Mathijs Baens, Jason G. Cyster, Narayanan Parameswaran, Margot Thome, Peter C. Lucas, Linda M. McAllister-Lucas

JOURNAL OF CLINICAL INVESTIGATION (2020)

Article Hematology

Molecular mechanism of two nanobodies that inhibit PAI-1 activity reveals a modulation at distinct stages of the PAI-1/plasminogen activator interaction

Machteld Sillen, Stephen D. Weeks, Xiaohua Zhou, Andrey A. Komissarov, Galina Florova, Steven Idell, Sergei V. Strelkov, Paul J. Declerck

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

Letter Biochemistry & Molecular Biology

Classification and Nomenclature of Metacaspases and Paracaspases: No More Confusion with Caspases

Elena A. Minina, Jens Staal, Vanina E. Alvarez, John A. Berges, Ilana Berman-Frank, Rudi Beyaert, Kay D. Bidle, Frederic Bornancin, Magali Casanova, Juan J. Cazzulo, Chang Jae Choi, Nuria S. Coll, Vishva M. Dixit, Marko Dolinar, Nicolas Fasel, Christiane Funk, Patrick Gallois, Kris Gevaert, Emilio Gutierrez-Beltran, Stephan Hailfinger, Marina Klemencic, Eugene V. Koonin, Daniel Krappmann, Anna Linusson, Mauricio F. M. Machado, Frank Madeo, Lynn A. Megeney, Panagiotis N. Moschou, Jeremy C. Mottram, Thomas Nystrom, Heinz D. Osiewacz, Christopher M. Overall, Kailash C. Pandey, Juergen Ruland, Guy S. Salvesen, Yigong Shi, Andrei Smertenko, Simon Stael, Jerry Stahlberg, Maria Fernanda Suarez, Margot Thome, Hannele Tuominen, Frank Van Breusegem, Renier A. L. van der Hoorn, Assaf Vardi, Boris Zhivotovsky, Eric Lam, Peter V. Bozhkov

MOLECULAR CELL (2020)

Article Oncology

Role of ETS1 in the Transcriptional Network of Diffuse Large B Cell Lymphoma of the Activated B Cell-Like Type

Valdemar Priebe, Giulio Sartori, Sara Napoli, Elaine Yee Lin Chung, Luciano Cascione, Ivo Kwee, Alberto Jesus Arribas, Afua Adjeiwaa Mensah, Andrea Rinaldi, Maurilio Ponzoni, Emanuele Zucca, Davide Rossi, Dimitar Efremov, Georg Lenz, Margot Thome, Francesco Bertoni

CANCERS (2020)

Article Immunology

Therapeutic Potential of Targeting Malt1-Dependent TCR Downstream Signaling to Promote the Survival of MHC-Mismatched Allografts

Lerisa Govender, Josip Mikulic, Jean-Christophe Wyss, Olivier Gaide, Margot Thome, Dela Golshayan

FRONTIERS IN IMMUNOLOGY (2020)

Article Chemistry, Medicinal

Synthesis and structure-activity studies of novel anhydrohexitol-based Leucyl-tRNA synthetase inhibitors

Dries De Ruysscher, Luping Pang, Stijn M. G. Lenders, Davie Cappoen, Paul Cos, Jef Rozenski, Sergei Strelkov, Stephen D. Weeks, Arthur Van Aerschot

Summary: LeuRS is a clinically validated target for antimicrobial development, and bi-substrate inhibitors have shown potent inhibitory activity against bacterial LeuRS. The results of the study could serve as a suitable starting point for further antibiotic development.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Review Biochemistry & Molecular Biology

Aminoacyl-tRNA Synthetases as Valuable Targets for Antimicrobial Drug Discovery

Luping Pang, Stephen D. Weeks, Arthur Van Aerschot

Summary: Aminoacyl-tRNA synthetases (aaRSs) are essential enzymes in all three kingdoms of life, and have been recognized as suitable targets for small molecule anti-infectives. This review discusses the catalytic activities of aaRSs, inhibitory mechanisms, and species-selectivity determinants of reported inhibitors. The structural perspective highlights opportunities for further exploration of the aaRS enzyme family as antimicrobial targets.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Multidisciplinary Sciences

The in-vitro effect of famotidine on sars-cov-2 proteases and virus replication

Madeline Loffredo, Hector Lucero, Da-Yuan Chen, Aoife O'Connell, Simon Bergqvist, Ahmad Munawar, Asanga Bandara, Steff De Graef, Stephen D. Weeks, Florian Douam, Mohsan Saeed, Ali H. Munawar

Summary: Multiple studies have suggested the repositioning of famotidine, an approved drug, for the treatment of COVID-19 due to the lack of specific antiviral drugs for the coronavirus. While potential molecular targets have been proposed, experimental results show that famotidine does not directly inhibit SARS-CoV-2 replication. Further research is needed to explore the molecular mechanism of famotidine in the context of COVID-19.

SCIENTIFIC REPORTS (2021)

Article Biochemistry & Molecular Biology

Towards Novel 3-Aminopyrazinamide-Based Prolyl-tRNA Synthetase Inhibitors: In Silico Modelling, Thermal Shift Assay and Structural Studies

Luping Pang, Stephen D. Weeks, Martin Juhas, Sergei Strelkov, Jan Zitko, Arthur Van Aerschot

Summary: HcProRS catalyzes prolyl-tRNA synthesis and inhibiting its activity may benefit treatment of fibrosis, autoimmune diseases, and cancer. Recent research identified potential novel HcProRS inhibitors from a pyrazinamide-based compound library, showing promise for repurposing old drug candidates for HcProRS-related diseases.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Oncology

ASB2 is a direct target of FLI1 that sustains NF-κB pathway activation in germinal center-derived diffuse large B-cell lymphoma

Giulio Sartori, Sara Napoli, Luciano Cascione, Elaine Yee Lin Chung, Valdemar Priebe, Alberto Jesus Arribas, Afua Adjeiwaa Mensah, Michela Dall'Angelo, Chiara Falzarano, Laura Barnabei, Mattia Forcato, Andrea Rinaldi, Silvio Bicciato, Margot Thome, Francesco Bertoni

Summary: FLI1 is more highly expressed in GCB DLBCL compared to ABC DLBCL and regulates a network of biologically crucial genes. It directly influences the NF-kappa B pathway at the transcriptional level and the alternative NF-kappa B pathway via ASB2, providing a potential new therapeutic approach for GCB DLBCL.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)

Article Biology

Partitioning of the initial catalytic steps of leucyl-tRNA synthetase is driven by an active site peptide-plane flip

Luping Pang, Vladimir Zanki, Sergei Strelkov, Arthur Van Aerschot, Ita Gruic-Sovulj, Stephen D. Weeks

Summary: Crystal structures of leucyl-tRNA synthetase in Neisseria gonorrhoeae reveal conformational changes and a peptide-plane flip in the active site that correlate with catalytic steps. These structural alterations have a significant impact on the enzyme's activity.

COMMUNICATIONS BIOLOGY (2022)

Article Biochemistry & Molecular Biology

Structural Basis of Cysteine Ligase MshC Inhibition by Cysteinyl-Sulfonamides

Luping Pang, Stijn Lenders, Evgenii M. Osipov, Stephen D. Weeks, Jef Rozenski, Tatiana Piller, Davie Cappoen, Sergei V. Strelkov, Arthur Van Aerschot

Summary: Mycothiol (MSH) is the major cellular thiol in Mycobacterium tuberculosis (Mtb) and plays a crucial role in the resistance to antibiotics and oxidative stresses. This study focused on MshC, an enzyme involved in the synthesis of MSH, and synthesized five new compounds with potential inhibitory effects on MshC. The compounds showed strong binding affinity with MshC, but did not suppress the growth of Mtb culture, possibly due to inadequate cellular uptake.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Biochemistry & Molecular Biology

Discovery of novel druggable pockets on polyomavirus VP1 through crystallographic fragment-based screening to develop capsid assembly inhibitors

Evgenii M. Osipov, Ali H. Munawar, Steven Beelen, Daren Fearon, Alice Douangamath, Conor Wild, Stephen D. Weeks, Arthur Van Aerschot, Frank von Delft, Sergei Strelkov

Summary: Polyomaviruses, including BK polyomavirus and Merkel cell polyomavirus, are human pathogens for which no specific drugs are available. In this study, we focused on the structural protein VP1 of BK polyomavirus and used high-throughput screening to identify drug-like fragments that bind to truncated VP1 pentamers. We found a total of 144 binding hits, which cluster in six surface pockets. These findings provide a foundation for rational drug design targeting polyomavirus capsid assembly.

RSC CHEMICAL BIOLOGY (2022)

Meeting Abstract Medicine, General & Internal

Targeting Malt1-dependent TCR downstream signaling to promote experimental allograft survival

Lerisa Govender, Josip Mikulic, Jean-Christophe Wyss, Olivier Gaide, Margot Thome, Dela Golshayan

SWISS MEDICAL WEEKLY (2020)

暂无数据